{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:31:37Z","timestamp":1793723497475,"version":"4.6.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Science Foundation of Jiangsu Province","award":["BK20221553"],"award-info":[{"award-number":["BK20221553"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001260"],"award-info":[{"award-number":["82001260"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101245"],"award-info":[{"award-number":["82101245"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271361"],"award-info":[{"award-number":["82271361"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11064-024-04272-z","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T02:12:51Z","timestamp":1731723171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Inhibition of PCSK9 Protects against Cerebral Ischemia\u2012Reperfusion Injury via Attenuating Microcirculatory Dysfunction"],"prefix":"10.1007","volume":"50","author":[{"given":"Yuanfei","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weichen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anyu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenya","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wusheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,16]]},"reference":[{"key":"4272_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/17474930211065917","volume":"17","author":"VL Feigin","year":"2022","unstructured":"Feigin VL, Brainin M, Norrving B, Martins S, Sacco RL, Hacke W, Fisher M, Pandian J, Lindsay P (2022) World Stroke Organization (WSO): global stroke fact sheet 2022. Int J Stroke 17:18\u201329. https:\/\/doi.org\/10.1177\/17474930211065917","journal-title":"Int J Stroke"},{"key":"4272_CR2","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B et al (2019) Guidelines for the early management of patients with Acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of Acute ischemic stroke: a Guideline for Healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 50:e344\u2013e418. https:\/\/doi.org\/10.1161\/STR.0000000000000211","journal-title":"Stroke"},{"key":"4272_CR3","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","volume":"387","author":"M Goyal","year":"2016","unstructured":"Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, Davalos A, Majoie CB, van der Lugt A, de Miquel MA et al (2016) Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 387:1723\u20131731. https:\/\/doi.org\/10.1016\/S0140-6736(16)00163-X","journal-title":"Lancet"},{"key":"4272_CR4","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/nm.2507","volume":"17","author":"HK Eltzschig","year":"2011","unstructured":"Eltzschig HK, Eckle T (2011) Ischemia and reperfusion\u2013from mechanism to translation. Nat Med 17:1391\u20131401. https:\/\/doi.org\/10.1038\/nm.2507","journal-title":"Nat Med"},{"key":"4272_CR5","doi-asserted-by":"publisher","unstructured":"Przykaza L (2021) Understanding the connection between common stroke comorbidities, their Associated inflammation, and the course of the cerebral Ischemia\/Reperfusion Cascade. Front Immunol 12. https:\/\/doi.org\/10.3389\/fimmu.2021.782569","DOI":"10.3389\/fimmu.2021.782569"},{"key":"4272_CR6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1177\/0271678X20914179","volume":"41","author":"SE Erdener","year":"2021","unstructured":"Erdener SE, Tang J, Kilic K, Postnov D, Giblin JT, Kura S, Chen IA, Vayisoglu T, Sakadzic S, Schaffer CB, Boas DA (2021) Dynamic capillary stalls in reperfused ischemic penumbra contribute to injury: a hyperacute role for neutrophils in persistent traffic jams. J Cereb Blood Flow Metab 41:236\u2013252. https:\/\/doi.org\/10.1177\/0271678X20914179","journal-title":"J Cereb Blood Flow Metab"},{"key":"4272_CR7","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1001\/jama.2022.1645","volume":"327","author":"A Renu","year":"2022","unstructured":"Renu A, Millan M, San Roman L, Blasco J, Marti-Fabregas J, Terceno M, Amaro S, Serena J, Urra X, Laredo C et al (2022) Effect of intra-arterial alteplase vs Placebo following successful thrombectomy on functional outcomes in patients with large vessel occlusion Acute ischemic stroke: the CHOICE Randomized Clinical Trial. JAMA 327:826\u2013835. https:\/\/doi.org\/10.1001\/jama.2022.1645","journal-title":"JAMA"},{"key":"4272_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12975-017-0562-2","volume":"9","author":"EM Arsava","year":"2018","unstructured":"Arsava EM, Arat A, Topcuoglu MA, Peker A, Yemisci M, Dalkara T (2018) Angiographic microcirculatory obstructions distal to occlusion signify poor outcome after Endovascular Treatment for Acute ischemic stroke. Transl Stroke Res 9:44\u201350. https:\/\/doi.org\/10.1007\/s12975-017-0562-2","journal-title":"Transl Stroke Res"},{"key":"4272_CR9","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1161\/STROKEAHA.114.007964","volume":"46","author":"TH Cho","year":"2015","unstructured":"Cho TH, Nighoghossian N, Mikkelsen IK, Derex L, Hermier M, Pedraza S, Fiehler J, Ostergaard L, Berthezene Y, Baron JC (2015) Reperfusion within 6 hours outperforms recanalization in predicting penumbra salvage, lesion growth, final infarct, and clinical outcome. Stroke 46:1582\u20131589. https:\/\/doi.org\/10.1161\/STROKEAHA.114.007964","journal-title":"Stroke"},{"key":"4272_CR10","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1080\/10408363.2016.1200008","volume":"53","author":"XR Xu","year":"2016","unstructured":"Xu XR, Zhang D, Oswald BE, Carrim N, Wang X, Hou Y, Zhang Q, Lavalle C, McKeown T, Marshall AH, Ni H (2016) Platelets are versatile cells: new discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond. Crit Rev Clin Lab Sci 53:409\u2013430. https:\/\/doi.org\/10.1080\/10408363.2016.1200008","journal-title":"Crit Rev Clin Lab Sci"},{"key":"4272_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12959-016-0100-6","volume":"14","author":"XR Xu","year":"2016","unstructured":"Xu XR, Carrim N, Neves MA, McKeown T, Stratton TW, Coelho RM, Lei X, Chen P, Xu J, Dai X et al (2016) Platelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapies. Thromb J 14:29. https:\/\/doi.org\/10.1186\/s12959-016-0100-6","journal-title":"Thromb J"},{"key":"4272_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.redox.2017.08.021","volume":"14","author":"J Qiao","year":"2018","unstructured":"Qiao J, Arthur JF, Gardiner EE, Andrews RK, Zeng L, Xu K (2018) Regulation of platelet activation and thrombus formation by reactive oxygen species. Redox Biol 14:126\u2013130. https:\/\/doi.org\/10.1016\/j.redox.2017.08.021","journal-title":"Redox Biol"},{"key":"4272_CR13","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1172\/JCI135530","volume":"130","author":"C Iadecola","year":"2020","unstructured":"Iadecola C, Buckwalter MS, Anrather J (2020) Immune responses to stroke: mechanisms, modulation, and therapeutic potential. J Clin Invest 130:2777\u20132788. https:\/\/doi.org\/10.1172\/JCI135530","journal-title":"J Clin Invest"},{"key":"4272_CR14","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1161\/STROKEAHA.118.020711","volume":"49","author":"A Taskiran-Sag","year":"2018","unstructured":"Taskiran-Sag A, Yemisci M, Gursoy-Ozdemir Y, Erdener SE, Karatas H, Yuce D, Dalkara T (2018) Improving Microcirculatory Reperfusion reduces Parenchymal Oxygen Radical formation and provides neuroprotection. Stroke 49:1267\u20131275. https:\/\/doi.org\/10.1161\/STROKEAHA.118.020711","journal-title":"Stroke"},{"key":"4272_CR15","doi-asserted-by":"publisher","unstructured":"Sundararaman SS, Doring Y, van der Vorst EPC (2021) PCSK9: A Multi-Faceted Protein That Is Involved in Cardiovascular Biology. Biomedicines 9.https:\/\/doi.org\/10.3390\/biomedicines9070793","DOI":"10.3390\/biomedicines9070793"},{"key":"4272_CR16","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.bcp.2019.04.003","volume":"164","author":"AJP Klein-Szanto","year":"2019","unstructured":"Klein-Szanto AJP, Bassi DE (2019) Keep recycling going: new approaches to reduce LDL-C. Biochem Pharmacol 164:336\u2013341. https:\/\/doi.org\/10.1016\/j.bcp.2019.04.003","journal-title":"Biochem Pharmacol"},{"key":"4272_CR17","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.jacc.2013.07.056","volume":"62","author":"D Urban","year":"2013","unstructured":"Urban D, Poss J, Bohm M, Laufs U (2013) Targeting the proprotein convertase subtilisin\/kexin type 9 for the treatment of dyslipidemia and atherosclerosis. J Am Coll Cardiol 62:1401\u20131408. https:\/\/doi.org\/10.1016\/j.jacc.2013.07.056","journal-title":"J Am Coll Cardiol"},{"key":"4272_CR18","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1016\/j.jacc.2019.08.1024","volume":"74","author":"MJ Koren","year":"2019","unstructured":"Koren MJ, Sabatine MS, Giugliano RP, Langslet G, Wiviott SD, Ruzza A, Ma Y, Hamer AW, Wasserman SM, Raal FJ (2019) Long-term efficacy and safety of Evolocumab in patients with hypercholesterolemia. J Am Coll Cardiol 74:2132\u20132146. https:\/\/doi.org\/10.1016\/j.jacc.2019.08.1024","journal-title":"J Am Coll Cardiol"},{"key":"4272_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jacc.2020.05.027","volume":"76","author":"DJ Blom","year":"2020","unstructured":"Blom DJ, Harada-Shiba M, Rubba P, Gaudet D, Kastelein JJP, Charng MJ, Pordy R, Donahue S, Ali S, Dong Y et al (2020) Efficacy and safety of Alirocumab in adults with homozygous familial hypercholesterolemia: the ODYSSEY HoFH Trial. J Am Coll Cardiol 76:131\u2013142. https:\/\/doi.org\/10.1016\/j.jacc.2020.05.027","journal-title":"J Am Coll Cardiol"},{"key":"4272_CR20","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1056\/NEJMoa1500858","volume":"372","author":"MS Sabatine","year":"2015","unstructured":"Sabatine MS, Giugliano RP, Wiviott SD, Raal FJ, Blom DJ, Robinson J, Ballantyne CM, Somaratne R, Legg J, Wasserman SM et al (2015) Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. N Engl J Med 372:1500\u20131509. https:\/\/doi.org\/10.1056\/NEJMoa1500858","journal-title":"N Engl J Med"},{"key":"4272_CR21","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1161\/STROKEAHA.119.027759","volume":"51","author":"RP Giugliano","year":"2020","unstructured":"Giugliano RP, Pedersen TR, Saver JL, Sever PS, Keech AC, Bohula EA, Murphy SA, Wasserman SM, Honarpour N, Wang H et al (2020) Stroke Prevention with the PCSK9 (Proprotein Convertase Subtilisin-Kexin type 9) inhibitor Evolocumab added to statin in high-risk patients with stable atherosclerosis. Stroke 51:1546\u20131554. https:\/\/doi.org\/10.1161\/STROKEAHA.119.027759","journal-title":"Stroke"},{"key":"4272_CR22","doi-asserted-by":"publisher","unstructured":"Zeng J, Tao J, Xi L, Wang Z, Liu L (2021) PCSK9 mediates the oxidative low\u2013density lipoprotein\u2013induced pyroptosis of vascular endothelial cells via the UQCRC1\/ROS pathway. Int J Mol Med 47. https:\/\/doi.org\/10.3892\/ijmm.2021.4886","DOI":"10.3892\/ijmm.2021.4886"},{"key":"4272_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1515\/med-2021-0400","volume":"17","author":"Q Wang","year":"2022","unstructured":"Wang Q, Zheng B, Chen P, Lei Y (2022) Leptin and PCSK9 concentrations are associated with vascular endothelial cytokines in patients with stable coronary heart disease. Open Med (Wars) 17:185\u2013190. https:\/\/doi.org\/10.1515\/med-2021-0400","journal-title":"Open Med (Wars)"},{"key":"4272_CR24","doi-asserted-by":"publisher","unstructured":"Song L, Zhao X, Chen R, Li J, Zhou J, Liu C, Zhou P, Wang Y, Chen Y, Zhao H, Yan H (2022) Association of PCSK9 with inflammation and platelet activation markers and recurrent cardiovascular risks in STEMI patients undergoing primary PCI with or without diabetes. Cardiovasc Diabetol 21. https:\/\/doi.org\/10.1186\/s12933-022-01519-3","DOI":"10.1186\/s12933-022-01519-3"},{"key":"4272_CR25","doi-asserted-by":"publisher","unstructured":"Cammisotto V, Pastori D, Nocella C, Bartimoccia S, Castellani V, Marchese C, Scavalli AS, Ettorre E, Viceconte N, Violi F et al (2020) PCSK9 regulates Nox2-Mediated platelet activation via CD36 receptor in patients with Atrial Fibrillation. Antioxid (Basel) 9. https:\/\/doi.org\/10.3390\/antiox9040296","DOI":"10.3390\/antiox9040296"},{"key":"4272_CR26","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.numecd.2019.09.012","volume":"30","author":"C Barale","year":"2020","unstructured":"Barale C, Bonomo K, Frascaroli C, Morotti A, Guerrasio A, Cavalot F, Russo I (2020) Platelet function and activation markers in primary hypercholesterolemia treated with anti-PCSK9 monoclonal antibody: a 12-month follow-up. Nutr Metab Cardiovasc Dis 30:282\u2013291. https:\/\/doi.org\/10.1016\/j.numecd.2019.09.012","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"4272_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1161\/CIRCULATIONAHA.120.046290","volume":"143","author":"Z Qi","year":"2021","unstructured":"Qi Z, Hu L, Zhang J, Yang W, Liu X, Jia D, Yao Z, Chang L, Pan G, Zhong H et al (2021) PCSK9 (Proprotein Convertase Subtilisin\/Kexin 9) enhances platelet activation, thrombosis, and myocardial infarct expansion by binding to platelet CD36. Circulation 143:45\u201361. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.046290","journal-title":"Circulation"},{"key":"4272_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00395-020-00832-w","volume":"115","author":"X Wang","year":"2020","unstructured":"Wang X, Li X, Liu S, Brickell AN, Zhang J, Wu Z, Zhou S, Ding Z (2020) PCSK9 regulates pyroptosis via mtDNA damage in chronic myocardial ischemia. Basic Res Cardiol 115:66. https:\/\/doi.org\/10.1007\/s00395-020-00832-w","journal-title":"Basic Res Cardiol"},{"key":"4272_CR29","doi-asserted-by":"crossref","unstructured":"Sun R, Peng M, Xu P, Huang F, Xie Y, Li J, Hong Y, Guo H, Liu Q, Zhu W (2020) Low-density lipoprotein receptor (LDLR) regulates NLRP3-mediated neuronal pyroptosis following cerebral ischemia\/reperfusion injury. J Neuroinflammation 17:330. https:\/\/doi.org\/10.1186\/s12974-020-01988-x","DOI":"10.1186\/s12974-020-01988-x"},{"key":"4272_CR30","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s00018-022-04257-7","volume":"79","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Shen C, Fang M, Han Y, Long C, Liu W, Yang M, Liu M, Zhang D, Cao Q et al (2022) Novel contact-kinin inhibitor sylvestin targets thromboinflammation and ameliorates ischemic stroke. Cell Mol Life Sci 79:240. https:\/\/doi.org\/10.1007\/s00018-022-04257-7","journal-title":"Cell Mol Life Sci"},{"key":"4272_CR31","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.redox.2018.06.012","volume":"18","author":"P Xu","year":"2018","unstructured":"Xu P, Liu Q, Xie Y, Shi X, Li Y, Peng M, Guo H, Sun R, Li J, Hong Y et al (2018) Breast cancer susceptibility protein 1 (BRCA1) rescues neurons from cerebral ischemia\/reperfusion injury through NRF2-mediated antioxidant pathway. Redox Biol 18:158\u2013172. https:\/\/doi.org\/10.1016\/j.redox.2018.06.012","journal-title":"Redox Biol"},{"key":"4272_CR32","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1161\/01.str.32.4.1005","volume":"32","author":"J Chen","year":"2001","unstructured":"Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M, Chopp M (2001) Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32:1005\u20131011. https:\/\/doi.org\/10.1161\/01.str.32.4.1005","journal-title":"Stroke"},{"key":"4272_CR33","doi-asserted-by":"publisher","unstructured":"Yoshizaki K, Asai M, Hara T (2020) High-Fat Diet enhances Working Memory in the Y-Maze test in male C57BL\/6J mice with less anxiety in the elevated plus maze test. Nutrients 12. https:\/\/doi.org\/10.3390\/nu12072036","DOI":"10.3390\/nu12072036"},{"key":"4272_CR34","doi-asserted-by":"publisher","unstructured":"Barisione C, Verzola D, Garibaldi S, Ferrari PF, Garibotto G, Ameri P, Pane B, Spinella G, Pratesi G, Palombo D (2021) Renal Ischemia\/Reperfusion early induces myostatin and PCSK9 expression in rat kidneys and HK-2 cells. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/ijms22189884","DOI":"10.3390\/ijms22189884"},{"key":"4272_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jcmgh.2023.09.004","volume":"17","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang Z, Jia C, Yu W, Li X, Xia N, Nie H, Wikana LP, Chen M, Ni Y et al (2024) Blockade of hepatocyte PCSK9 ameliorates hepatic ischemia-reperfusion Injury by promoting Pink1-Parkin-mediated Mitophagy. Cell Mol Gastroenterol Hepatol 17:149\u2013169. https:\/\/doi.org\/10.1016\/j.jcmgh.2023.09.004","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"4272_CR36","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1161\/CIRCRESAHA.122.319951","volume":"130","author":"NS Rost","year":"2022","unstructured":"Rost NS, Brodtmann A, Pase MP, van Veluw SJ, Biffi A, Duering M, Hinman JD, Dichgans M (2022) Post-stroke Cognitive Impairment and Dementia. Circ Res 130:1252\u20131271. https:\/\/doi.org\/10.1161\/CIRCRESAHA.122.319951","journal-title":"Circ Res"},{"key":"4272_CR37","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1017\/S1041610215000988","volume":"27","author":"H Schottke","year":"2015","unstructured":"Schottke H, Giabbiconi CM (2015) Post-stroke depression and post-stroke anxiety: prevalence and predictors. Int Psychogeriatr 27:1805\u20131812. https:\/\/doi.org\/10.1017\/S1041610215000988","journal-title":"Int Psychogeriatr"},{"key":"4272_CR38","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1161\/STROKEAHA.122.036946","volume":"53","author":"E Candelario-Jalil","year":"2022","unstructured":"Candelario-Jalil E, Dijkhuizen RM, Magnus T (2022) Neuroinflammation, Stroke, blood-brain barrier dysfunction, and Imaging modalities. Stroke 53:1473\u20131486. https:\/\/doi.org\/10.1161\/STROKEAHA.122.036946","journal-title":"Stroke"},{"key":"4272_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/01.RES.0000252802.25497.b7","volume":"100","author":"P von Hundelshausen","year":"2007","unstructured":"von Hundelshausen P, Weber C (2007) Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 100:27\u201340. https:\/\/doi.org\/10.1161\/01.RES.0000252802.25497.b7","journal-title":"Circ Res"},{"key":"4272_CR40","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/jcbfm.2015.45","volume":"35","author":"GC Jickling","year":"2015","unstructured":"Jickling GC, Liu D, Ander BP, Stamova B, Zhan X, Sharp FR (2015) Targeting neutrophils in ischemic stroke: translational insights from experimental studies. J Cereb Blood Flow Metab 35:888\u2013901. https:\/\/doi.org\/10.1038\/jcbfm.2015.45","journal-title":"J Cereb Blood Flow Metab"},{"key":"4272_CR41","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1182\/blood-2012-04-426734","volume":"121","author":"C Kleinschnitz","year":"2013","unstructured":"Kleinschnitz C, Kraft P, Dreykluft A, Hagedorn I, Gobel K, Schuhmann MK, Langhauser F, Helluy X, Schwarz T, Bittner S et al (2013) Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood 121:679\u2013691. https:\/\/doi.org\/10.1182\/blood-2012-04-426734","journal-title":"Blood"},{"key":"4272_CR42","doi-asserted-by":"publisher","first-page":"384685","DOI":"10.1155\/2012\/384685","volume":"2012","author":"C Li","year":"2012","unstructured":"Li C, Li J, Li Y, Lang S, Yougbare I, Zhu G, Chen P, Ni H (2012) Crosstalk between platelets and the Immune System: Old systems with New discoveries. Adv Hematol 2012:384685. https:\/\/doi.org\/10.1155\/2012\/384685","journal-title":"Adv Hematol"},{"key":"4272_CR43","doi-asserted-by":"publisher","unstructured":"Jin R, Yu S, Song Z, Zhu X, Wang C, Yan J, Wu F, Nanda A, Granger DN, Li G (2013) Soluble CD40 ligand stimulates CD40-dependent activation of the beta2 integrin Mac-1 and protein kinase C zeda (PKCzeta) in neutrophils: implications for neutrophil-platelet interactions and neutrophil oxidative burst. PLoS ONE 8. https:\/\/doi.org\/10.1371\/journal.pone.0064631","DOI":"10.1371\/journal.pone.0064631"},{"key":"4272_CR44","doi-asserted-by":"publisher","first-page":"104275","DOI":"10.1016\/j.ebiom.2022.104275","volume":"84","author":"X Zhang","year":"2022","unstructured":"Zhang X, Gong P, Zhao Y, Wan T, Yuan K, Xiong Y, Wu M, Zha M, Li Y, Jiang T et al (2022) Endothelial caveolin-1 regulates cerebral thrombo-inflammation in acute ischemia\/reperfusion injury. EBioMedicine 84:104275. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104275","journal-title":"EBioMedicine"},{"key":"4272_CR45","doi-asserted-by":"publisher","first-page":"1127534","DOI":"10.3389\/fnagi.2023.1127534","volume":"15","author":"L Wu","year":"2023","unstructured":"Wu L, Kong Q, Huang H, Xu S, Qu W, Zhang P, Yu Z, Luo X (2023) Effect of PCSK9 inhibition in combination with statin therapy on intracranial atherosclerotic stenosis: a high-resolution MRI study. Front Aging Neurosci 15:1127534. https:\/\/doi.org\/10.3389\/fnagi.2023.1127534","journal-title":"Front Aging Neurosci"},{"key":"4272_CR46","doi-asserted-by":"publisher","first-page":"117180","DOI":"10.1016\/j.atherosclerosis.2023.06.971","volume":"378","author":"R Marfella","year":"2023","unstructured":"Marfella R, Prattichizzo F, Sardu C, Paolisso P, D\u2019Onofrio N, Scisciola L, La Grotta R, Frige C, Ferraraccio F, Panarese I et al (2023) Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque. Atherosclerosis 378:117180. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.06.971","journal-title":"Atherosclerosis"},{"key":"4272_CR47","doi-asserted-by":"publisher","first-page":"14360","DOI":"10.1038\/s41598-017-14307-x","volume":"7","author":"H Wang","year":"2017","unstructured":"Wang H, Wang Q, Wang J, Guo C, Kleiman K, Meng H, Knight JS, Eitzman DT (2017) Proprotein convertase subtilisin\/kexin type 9 (PCSK9) Deficiency is protective against venous thrombosis in mice. Sci Rep 7:14360. https:\/\/doi.org\/10.1038\/s41598-017-14307-x","journal-title":"Sci Rep"},{"key":"4272_CR48","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1007\/s00415-021-10597-4","volume":"269","author":"J Guo","year":"2022","unstructured":"Guo J, Wang J, Sun W, Liu X (2022) The advances of post-stroke depression: 2021 update. J Neurol 269:1236\u20131249. https:\/\/doi.org\/10.1007\/s00415-021-10597-4","journal-title":"J Neurol"},{"key":"4272_CR49","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1007\/s00018-012-0977-6","volume":"69","author":"K Kysenius","year":"2012","unstructured":"Kysenius K, Muggalla P, Matlik K, Arumae U, Huttunen HJ (2012) PCSK9 regulates neuronal apoptosis by adjusting ApoER2 levels and signaling. Cell Mol Life Sci 69:1903\u20131916. https:\/\/doi.org\/10.1007\/s00018-012-0977-6","journal-title":"Cell Mol Life Sci"},{"key":"4272_CR50","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.3892\/ijmm.2018.3797","volume":"42","author":"L Wang","year":"2018","unstructured":"Wang L, Wang Z, Shi J, Jiang Q, Wang H, Li X, Hao D (2018) Inhibition of proprotein convertase subtilisin\/kexin type 9 attenuates neuronal apoptosis following focal cerebral ischemia via apolipoprotein E receptor 2 downregulation in hyperlipidemic mice. Int J Mol Med 42:2098\u20132106. https:\/\/doi.org\/10.3892\/ijmm.2018.3797","journal-title":"Int J Mol Med"},{"key":"4272_CR51","doi-asserted-by":"crossref","unstructured":"Abuelezz SA, Hendawy N (2021) HMGB1\/RAGE\/TLR4 axis and glutamate as novel targets for PCSK9 inhibitor in high fat cholesterol diet induced cognitive impairment and amyloidosis. Life Sci 273:119310. https:\/\/doi.org\/10.1016\/j.lfs.2021.119310","DOI":"10.1016\/j.lfs.2021.119310"},{"key":"4272_CR52","doi-asserted-by":"publisher","unstructured":"Arunsak B, Pratchayasakul W, Amput P, Chattipakorn K, Tosukhowong T, Kerdphoo S, Jaiwongkum T, Thonusin C, Palee S, Chattipakorn N, Chattipakorn SC (2020) Proprotein convertase subtilisin\/kexin type 9 (PCSK9) inhibitor exerts greater efficacy than atorvastatin on improvement of brain function and cognition in obese rats. Arch Biochem Biophys 689. https:\/\/doi.org\/10.1016\/j.abb.2020.108470","DOI":"10.1016\/j.abb.2020.108470"},{"key":"4272_CR53","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s00018-022-04237-x","volume":"79","author":"AD Mazura","year":"2022","unstructured":"Mazura AD, Ohler A, Storck SE, Kurtyka M, Scharfenberg F, Weggen S, Becker-Pauly C, Pietrzik CU (2022) PCSK9 acts as a key regulator of Abeta clearance across the blood-brain barrier. Cell Mol Life Sci 79:212. https:\/\/doi.org\/10.1007\/s00018-022-04237-x","journal-title":"Cell Mol Life Sci"},{"key":"4272_CR54","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1161\/CIRCULATIONAHA.123.062788","volume":"148","author":"X Zhang","year":"2023","unstructured":"Zhang X, Xu H, Yu J, Cui J, Chen Z, Li Y, Niu Y, Wang S, Ran S, Zou Y et al (2023) Immune Regulation of the liver through the PCSK9\/CD36 pathway during heart transplant rejection. Circulation 148:336\u2013353. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.062788","journal-title":"Circulation"},{"key":"4272_CR55","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1177\/0271678X231154602","volume":"43","author":"ID Kim","year":"2023","unstructured":"Kim ID, Ju H, Minkler J, Jiang R, Singh A, Sharma R, Febbraio M, Cho S (2023) Endothelial cell CD36 mediates stroke-induced brain injury via BBB dysfunction and monocyte infiltration in normal and obese conditions. J Cereb Blood Flow Metab 43:843\u2013855. https:\/\/doi.org\/10.1177\/0271678X231154602","journal-title":"J Cereb Blood Flow Metab"},{"key":"4272_CR56","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvad126","author":"P Zong","year":"2023","unstructured":"Zong P, Feng J, Li CX, Jellison ER, Yue Z, Miller B, Yue L (2023) Activation of endothelial TRPM2 exacerbates blood-brain barrier degradation in ischemic stroke. Cardiovasc Res. https:\/\/doi.org\/10.1093\/cvr\/cvad126","journal-title":"Cardiovasc Res"},{"key":"4272_CR57","doi-asserted-by":"publisher","first-page":"107517","DOI":"10.1016\/j.jstrokecerebrovasdis.2023.107517","volume":"33","author":"L Chen","year":"2024","unstructured":"Chen L, Du Y, Qiao H, Yang L, Zhang P, Wang J, Zhang C, Jiang W, Xu R, Zhang X (2024) Proprotein convertase subtilisin\/kexin type 9 inhibitor ameliorates cerebral ischemia in mice by inhibiting inflammation. J Stroke Cerebrovasc Dis 33:107517. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2023.107517","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"4272_CR58","doi-asserted-by":"publisher","first-page":"111195","DOI":"10.1016\/j.intimp.2023.111195","volume":"126","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Zhu T, Li G, Xu L, Zhang Y (2024) PCSK9 inhibitor protects against ischemic cerebral injury by attenuating inflammation via the GPNMB\/CD44 pathway. Int Immunopharmacol 126:111195. https:\/\/doi.org\/10.1016\/j.intimp.2023.111195","journal-title":"Int Immunopharmacol"},{"key":"4272_CR59","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1194\/jlr.M014118","volume":"52","author":"E Rousselet","year":"2011","unstructured":"Rousselet E, Marcinkiewicz J, Kriz J, Zhou A, Hatten ME, Prat A, Seidah NG (2011) PCSK9 reduces the protein levels of the LDL receptor in mouse brain during development and after ischemic stroke. J Lipid Res 52:1383\u20131391. https:\/\/doi.org\/10.1194\/jlr.M014118","journal-title":"J Lipid Res"},{"key":"4272_CR60","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10753-022-01715-z","volume":"46","author":"L Huang","year":"2023","unstructured":"Huang L, Li Y, Cheng Z, Lv Z, Luo S, Xia Y (2023) PCSK9 promotes endothelial dysfunction during Sepsis Via the TLR4\/MyD88\/NF-kappaB and NLRP3 pathways. Inflammation 46:115\u2013128. https:\/\/doi.org\/10.1007\/s10753-022-01715-z","journal-title":"Inflammation"},{"key":"4272_CR61","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1093\/cvr\/cvz262","volume":"116","author":"S Liu","year":"2020","unstructured":"Liu S, Deng X, Zhang P, Wang X, Fan Y, Zhou S, Mu S, Mehta JL, Ding Z (2020) Blood flow patterns regulate PCSK9 secretion via MyD88-mediated pro-inflammatory cytokines. Cardiovasc Res 116:1721\u20131732. https:\/\/doi.org\/10.1093\/cvr\/cvz262","journal-title":"Cardiovasc Res"},{"key":"4272_CR62","doi-asserted-by":"publisher","unstructured":"Ma B, Wang X, Zhang R, Niu S, Rong Z, Ni L, Di X, Han Q, Liu C (2021) Cigarette smoke extract stimulates PCSK9 production in HepG2 cells via ROS\/NF\u2013kappaB signaling. Mol Med Rep 23. https:\/\/doi.org\/10.3892\/mmr.2021.11970","DOI":"10.3892\/mmr.2021.11970"},{"key":"4272_CR63","doi-asserted-by":"publisher","unstructured":"Matsubara Y, Kiyohara H, Teratani T, Mikami Y, Kanai T (2022) Organ and brain crosstalk: the liver-brain axis in gastrointestinal, liver, and pancreatic diseases. Neuropharmacology 205. https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108915","DOI":"10.1016\/j.neuropharm.2021.108915"},{"key":"4272_CR64","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1126\/science.abi6087","volume":"374","author":"G Agirman","year":"2021","unstructured":"Agirman G, Yu KB, Hsiao EY (2021) Signaling inflammation across the gut-brain axis. Science 374:1087\u20131092. https:\/\/doi.org\/10.1126\/science.abi6087","journal-title":"Science"},{"key":"4272_CR65","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1016\/j.neuron.2023.06.002","volume":"111","author":"Y Wu","year":"2023","unstructured":"Wu Y, Dong JH, Dai YF, Zhu MZ, Wang MY, Zhang Y, Pan YD, Yuan XR, Guo ZX, Wang CX et al (2023) Hepatic soluble epoxide hydrolase activity regulates cerebral abeta metabolism and the pathogenesis of Alzheimer\u2019s disease in mice. Neuron 111:2847\u20132862. https:\/\/doi.org\/10.1016\/j.neuron.2023.06.002","journal-title":"Neuron"},{"key":"4272_CR66","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s40168-023-01648-1","volume":"11","author":"X Zeng","year":"2023","unstructured":"Zeng X, Li J, Shan W, Lai Z, Zuo Z (2023) Gut microbiota of old mice worsens neurological outcome after brain ischemia via increased valeric acid and IL-17 in the blood. Microbiome 11:204. https:\/\/doi.org\/10.1186\/s40168-023-01648-1","journal-title":"Microbiome"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-024-04272-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-024-04272-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-024-04272-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T12:04:44Z","timestamp":1738411484000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-024-04272-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,16]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["4272"],"URL":"https:\/\/doi.org\/10.1007\/s11064-024-04272-z","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,16]]},"assertion":[{"value":"5 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This study was performed in accordance with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University (Date 2022-03-07\/No. 2022DZGKJDWLS-0043).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}}],"article-number":"10"}}